On June 11, 2025, Tonix Pharmaceuticals signed a Sales Agreement to sell up to $150 million in shares via A.G.P./Alliance Global Partners and a Purchase Agreement to sell up to $75 million to Lincoln Park Capital. This allows the company to raise capital for general purposes with certain terms and conditions in place.